Among those, 8 miRNAs were deregulated in CML independently from BCR-ABL kinase activity and therefore are likely to be involved in the BCR-ABL-independent resistance to TKI that characterizes CML LSCs. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.